The University of Tennessee Graduate School of Medicine, Knoxville

The Department of Medicine

Hematology/Oncology Fellowship Program

The Hematology/Oncology Fellowship program is a fully ACGME-approved program for the University of Tennessee Graduate School of Medicine. We are currently accepting applications for the start of the 2025-2026 academic year with two open positions. This is a combined three-year training program preparing fellows for ABIM board eligibility in both hematology and medical oncology. We recruit two new fellows each year for a maximum of six fellows. Please find out more details on how to apply via ERAS.

Our Hematology/Oncology Fellowship program trains internal medicine graduates to become dual-board eligible in hematology and medical oncology. They receive education and field-training in the following course rotations:

  1. Normal and disease state fundamentals
  2. Molecular basis of cancer and hematologic diseases
  3. Principles of prevention and early detection of disease
  4. Treatments based on disease pathophysiology in unity with the patient’s goals
  5. Communication skills to deliver bad news empathetically

Participation by fellows in teaching residents and medical students is an integral part of the training.

Fellows have ample opportunities to enhance their research skills (both basic science and translational science) with multiple avenues to conduct research in their areas of interest. For example, they participate in cancer-related clinical trials through the Office of Clinical Trials and will explore the Bone Marrow Transplantation and Cellular Therapy Program at University of Tennessee Medical Center. This program serves a huge need in the East TN region and provides both autologous and allogeneic transplantation as well as innovative therapies such as chimeric antigen receptor cells (CAR-T) therapy. They have developed relationships with most commercial CAR-T companies to allow patients access to all available FDA-approved CAR-T products. Fellows may work with Dr. Jonathan Wall and the Amyloidosis and Cancer Theranostics Program (ACTP) for their clinical studies. Their work aims to improve the prognosis and quality of life for patients with amyloidosis through the development of additional imaging agents, and most importantly, new treatments designed to clear amyloid aggregates from the body.

Get to Know Us

Timothy J. Panella, MD
Program Director

Rajiv Dhand, MD
Chair of Medicine

Center of Excellence

The Cancer Institute is one of the medical center's six Centers of Excellence. Each center is dedicated to providing comprehensive care to patients and expert commitment plays a critical role in the hospital's ongoing success. The Cancer Institute brings together expertise in clinical care, teaching and research. Patients receive exceptional healthcare combined with patient-centered care, premier technology and extensive patient/community education in one convenient outpatient facility.

Program Strengths

Our Campus

Cancer Institute

The Cancer Institute provides comprehensive cancer services, from prevention to treatment. Learn more.



Support The University of Tennessee Graduate School of Medicine

The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290

Copyright © 2023